Janssen Business Development

Identifying Pathways to Better Health
Through Collaboration
Janssen Business Development
About Us

Johnson & Johnson Innovation | Janssen Business Development seeks to identify collaborative opportunities that will create transformative value for our partners and the world.

Driving Collaborative Innovation to Accelerate Breakthroughs

If you are with an established pharmaceutical company, mid-sized to large biotechnology company, seek a collaboration or merger & acquisition discussions, or have a compound that has shown proof of concept in humans, make the connection with Johnson & Johnson Innovation, Janssen Business Development.

Janssen Business Development is very active in acquiring assets, companies, and technologies as well as entering into strategic collaborations, including joint ventures, developments, and commercial partnerships.


The Janssen Business Development team focuses on mid- and late-stage collaborations with established pharmaceutical and larger biotechnology companies to accelerate breakthrough innovation to solve unmet medical needs and create real value in Janssen’s six defined therapeutic areas.

Strong Science Is at the Heart of Everything We Do

Our approach meaningfully integrates deal makers with science leaders from the very beginning. Having a clear and focused strategy that is grounded in the science allows the Janssen Business Development team to shape better deals and achieve in-market impact faster by understanding where each partner can add value.

Proven Two-Way Value Can Be Found in Every Partnership

The Janssen Business Development team has a proven, positive track record of deal performance. Our thoughtful approach to risk-taking includes spending the time to understand the needs of our partners so that deals can be structured to maximize value for all parties.

Dynamic Approaches Pave the Way to Success

Since no two deals are exactly alike, the Janssen Business Development team employs a flexible and adaptive approach to tailor the optimal deal structure to each unique partner opportunity. Our direct access to decision makers within Johnson & Johnson allows for creative and timely problem solving to optimize success.

True Collaboration Drives All of Our Actions

We are focused on genuine collaborations and seek out relationships with partners who desire transparency and openness, which we believe leads to new ideas and better solutions. Our goal is to form active partnerships where we can bring the full strength of Johnson & Johnson to bear to create a lasting and valuable relationship.

Focus Areas

Our Pharmaceuticals business is divided into six core areas, Cardiovascular & Metabolism; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension. Janssen Business Development seeks innovation across all of these areas where there is significant unmet patient need. 

  • Type 2 Diabetes
    Cardiovascular and Metabolism
    Cardiovascular and Metabolism
  • Psoriasis, Inflammatory Bowel Disease, Rheumatoid Arthritis
  • Respiratory Infections, Hepatitis
    Diseases and Vaccines
    Infectious Diseases and Vaccines
  • Mood Disorders, Alzheimer's Disease
  • Prostate Cancer, Lung Cancer, Hematologic Malignancies
  • Pulmonary arterial hypertension, Idiopathic pulmonary fibrosis, Chronic thromboembolic pulmonary hypertension
    Pulmonary Hypertension
    Pulmonary Hypertension

Janssen Enters Worldwide Collaboration and License Agreement with Meir...

Janssen Affiliate Cilag GmbH International Enters Worldwide Collaborat...

Janssen Announces Exclusive, Worldwide License Agreement With Arrowhea...

Contact us

Make the Connection

We look forward to our first discussion. If you would like to discuss a collaboration,
simply click the contact us button which will connect you to our Idea Portal and a member of our team will contact you.

Johan Verbeeck, DVM, MsC
Johnson & Johnson Innovation,
Janssen Business Development
Email: jverbee2@ITS.JNJ.com
Telephone: +1 609-730-4532